6533b821fe1ef96bd127c4ff

RESEARCH PRODUCT

Antibiotic resistance among Shigella serogroups isolated in Tehran, Iran (2002-2004)

Caterina MamminaMohammad Reza PourshafieReza RanjbarMohammad Mahdi Soltan-dallal

subject

medicine.medical_specialtyShigellosisSevere diseaseIranSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeMicrobiologyMicrobiologyAntibiotic resistanceVirologyAntibiotic therapyInternal medicineDrug Resistance BacterialmedicineHumansShigellaChildDysentery BacillaryShigella Antibiotic resistance IranTransmission (medicine)Diarrhoeal diseasebusiness.industryGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesChild PreschoolParasitologyShigellabusiness

description

Shigellosis, one of the most common bacterial diarrhoeal diseases, is endemic throughout the world. It is one of the major causes of morbidity in children with diarrhoea in Iran [1-4]. Antibiotic therapy is useful and effective for shigellosis. Treatment is critical for persons with severe disease, particularly children and immunosuppressed patients. Use of an appropriate antibiotic therapy can shorten the duration of symptoms, significantly reduce the risk of transmission, and also prevent potentially lethal complications [5-7]. However, high frequencies of resistance in

yearjournalcountryeditionlanguage
2009-09-15The Journal of Infection in Developing Countries
https://doi.org/10.3855/jidc.560